P2Y12 receptor antagonists: a rapidly expanding group of antiplatelet agents.
Marco
M
Cattaneo
D000241:Adenosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D050197:Atherosclerosis / Q000188:drug therapy*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D058919:Purinergic P2 Receptor Antagonists; D000077486:Ticagrelor
D010975:Platelet Aggregation Inhibitors; D058919:Purinergic P2 Receptor Antagonists; D000077486:Ticagrelor; D000241:Adenosine